rFVIIa (Novoseven): the new panacea?
Ickx
B E
BE
Anaesthesiology Department, Hôpital Erasme, 808, route de Lennik, 1070 Bruxelles.
D005167:Factor VII / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D015942:Factor VIIa; D006467:Hemophilia A / Q000188:drug therapy*; D006470:Hemorrhage / Q000517:prevention & control*; D006801:Humans; D011994:Recombinant Proteins / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*
D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa